References

The pathophysiology and treatment of glaucoma

10.1001/jama.2014.3192 · 2014 · External reference

Glaucomatous damage of the macula

10.1016/j.preteyeres.2012.08.003 · 2013 · External reference

Associations between glaucomatous visual field loss and participation in activities of daily living

10.1046/j.1442-9071.2003.00712.x · 2003 · External reference

Glaucoma and disability: which tasks are affected, and at what stage of disease?

10.1097/icu.0b013e32832401a9 · 2009 · External reference

Glaucoma and mobility performance. The Salisbury Eye Evaluation Project

10.1016/j.ophtha.2007.02.001 · 2007 · External reference

Glaucoma and driving: on-road driving characteristics.

10.1371/journal.pone.0158318 · 2016 · External reference

Glaucoma and on-road driving performance

10.1167/iovs.07-1609 · 2008 · External reference

Global data on visual impairment in the year 2002

2004 · External reference

The number of people with glaucoma worldwide in 2010 and 2020

10.1136/bjo.2005.081224 · 2006 · External reference

Impact of visual field loss on health-related quality of life in glaucoma

10.1016/j.ophtha.2007.08.037 · 2008 · External reference

Quality of life in glaucoma: a review of the literature

10.1007/s12325-016-0333-6 · 2016 · External reference

Visual impairment and falls in older adults: The Blue Mountains Eye Study

10.1111/j.1532-5415.1998.tb01014.x · 1998 · External reference

Risk of falls and motor vehicle collisions in glaucoma

10.1167/iovs.06-0886 · 2007 · External reference

High prevalence of anxiety and depression in patients with primary open-angle glaucoma

10.1097/ijg.0b013e31816299d4 · 2008 · External reference

Cognitive performance of primary open-angle glaucoma and normal-tension glaucoma patients

10.5935/0004-2749.20160030 · 2016 · External reference

Cognitive evaluation of patients with glaucoma and its comparison with individuals with Alzheimer’s disease

10.1007/s10792-017-0658-4 · 2018 · External reference

Dementia is associated with open-angle glaucoma: a population-based study

10.1038/eye.2015.120 · 2015 · External reference

Association between glaucoma and the risk of dementia

10.1097/md.0000000000002833 · 2016 · External reference

Macular pigment in the human retina: histological evaluation of localization and distribution

10.1038/sj.eye.6702780 · 2008 · External reference

Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration

10.1097/iae.0000000000000174 · 2014 · External reference

Macular pigment optical density is lower in type 2 diabetes, compared with type 1 diabetes and normal controls

10.1097/iae.0000000000000551 · 2015 · External reference

A review of the putative causal mechanisms associated with lower macular pigment in diabetes mellitus

10.1017/s095442241900012x · 2019 · External reference

Evidence of lower macular pigment optical density in chronic open angle glaucoma

10.1136/bjophthalmol-2013-303153 · 2013 · External reference

Lower macular pigment optical density in foveal-involved glaucoma

10.1016/j.ophtha.2015.06.028 · 2015 · External reference

Macular pigment optical density in Chinese primary open angle glaucoma using the one-wavelength reflectometry method

2016 · External reference

Association between lutein and zeaxanthin status and the risk of cataract: a meta-analysis

10.3390/nu6010452 · 2014 · External reference

Supplementation with all three macular carotenoids: response, stability, and safety

10.1167/iovs.11-8025 · 2011 · External reference

Safety evaluation of meso-zeaxanthin

10.1016/j.foodcont.2013.02.007 · 2013 · External reference

Unresolved reference

External reference

Quality of life in glaucoma and its relationship with visual function

10.1097/00061198-200304000-00009 · 2003 · External reference

Reliability of a two-wavelength autofluorescence technique by Heidelberg Spectralis to measure macular pigment optical density in Asian subjects

10.1016/j.exer.2017.12.015 · 2018 · External reference

Macular pigment optical density fluctuation as a function of pupillary mydriasis: methodological considerations for dual-wavelength autofluorescence

10.1080/02713683.2020.1815792 · 2021 · External reference

Macular pigment is associated with glare-affected visual function and central visual field loss in glaucoma

10.1136/bjophthalmol-2017-310215 · 2018 · External reference

Simultaneous noninvasive clinical measurement of lens autofluorescence and Rayleigh scattering using a fluorescence biomicroscope

10.1177/193229681200600603 · 2012 · External reference

Measurement of lens autofluorescence can distinguish subjects with diabetes from those without

10.1177/1932296813516955 · 2014 · External reference

Lens autofluorescence and light scatter in relation to the lens opacities classification system, LOCS III

10.1034/j.1600-0420.1999.770504.x · 1999 · External reference

The impact of cataract, and its surgical removal, on measures of macular pigment using the Heidelberg Spectralis HRA+OCT MultiColor device

10.1167/iovs.16-19141 · 2016 · External reference

GPOWER: a general power analysis program

10.3758/bf03203630 · 1996 · External reference

Unresolved reference

External reference

Unresolved reference

2016 · External reference

Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: The Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973

10.1016/j.optm.2011.08.008 · 2011 · External reference

Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study

10.1167/iovs.12-10715 · 2013 · External reference

The impact of macular pigment augmentation on visual performance using different carotenoid formulations

10.1167/iovs.12-10690 · 2012 · External reference

Lutein, zeaxanthin and meso-zeaxanthin supplementation associated with macular pigment optical density

10.3390/nu8070426 · 2016 · External reference

The impact of supplemental antioxidants on visual function in nonadvanced age-related macular degeneration: a head-to-head randomized clinical trial

10.1167/iovs.16-21192 · 2017 · External reference

Macular pigment and visual function in patients with glaucoma: The San Diego Macular Pigment Study

10.1167/iovs.18-24170 · 2018 · External reference

Low macular pigment levels are associated with manifest primary open-angle glaucoma in the Carotenoids in Age-Related Eye Disease Study Author Block

2021 · External reference

Cataract is a self-defence reaction to protect the retina from oxidative damage

10.1016/j.mehy.2011.02.013 · 2011 · External reference

Vascular dysregulation: a principal risk factor for glaucomatous damage?

10.1097/00061198-199906000-00012 · 1999 · External reference

Macular pigment and its contribution to vision

10.3390/nu5061962 · 2013 · External reference

Macular pigment and its contribution to visual performance and experience

10.1016/s1888-4296(10)70011-x · 2010 · External reference

Neuroprotective effects of lutein in the retina

10.2174/138161212798919101 · 2012 · External reference

Lutein, zeaxanthin, and meso-zeaxanthin: the basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease

10.1016/j.preteyeres.2015.10.003 · 2016 · External reference

Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement

10.1016/j.ophtha.2011.11.003 · 2012 · External reference

Dietary antioxidants, macular pigment, and glaucomatous neurodegeneration: a review of the evidence

10.3390/nu11051002 · 2019 · External reference

Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients

10.1016/s0002-9343(03)00114-1 · 2003 · External reference

Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma

10.1001/archopht.123.4.458 · 2005 · External reference

The role of N-methyl-D-aspartate receptor activation in homocysteine-induced death of retinal ganglion cells

10.1167/iovs.10-6870 · 2011 · External reference

Acute energy reduction induces caspase-dependent apoptosis and activates p53 in retinal ganglion cells (RGC-5)

10.1016/j.exer.2009.06.004 · 2009 · External reference

Retinal oxidative stress induced by high intraocular pressure

10.1016/j.freeradbiomed.2004.06.001 · 2004 · External reference

The role of inflammation in the pathogenesis of glaucoma

10.1016/j.survophthal.2012.08.010 · 2013 · External reference

Immediate upregulation of proteins belonging to different branches of the apoptotic cascade in the retina after optic nerve transection and optic nerve crush

10.1167/iovs.08-2404 · 2009 · External reference

Macular pigment: influences on visual acuity and visibility

10.1016/s1350-9462(02)00003-4 · 2002 · External reference

Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye

10.1146/annurev.nutr.23.011702.073307 · 2003 · External reference

Patients’ perception of visual impairment in glaucoma: a pilot study

10.1136/bjo.83.5.546 · 1999 · External reference

Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration

10.1016/j.ophtha.2012.08.040 · 2013 · External reference

Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study

10.1016/j.exer.2006.12.010 · 2007 · External reference

Macular carotenoid supplementation improves disability glare performance and dynamics of photostress recovery

10.1186/s40662-016-0060-8 · 2016 · External reference

Macular pigment and visual performance under glare conditions

10.1097/opx.0b013e318162266e · 2008 · External reference

Nutritional supplementation in the treatment of glaucoma: a systematic review

10.1016/j.survophthal.2018.09.005 · 2019 · External reference

Identification of progressive glaucomatous visual field loss

10.1016/s0039-6257(01)00299-5 · 2002 · External reference

Frequency of testing to detect visual field progression derived using a longitudinal cohort of glaucoma patients

10.1016/j.ophtha.2017.01.027 · 2017 · External reference

Practical recommendations for measuring rates of visual field change in glaucoma

10.1136/bjo.2007.135012 · 2008 · External reference

A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study

10.1016/j.ajo.2010.09.026 · 2011 · External reference